Karp SE - Search Results

1

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A. Boileau JF, et al. Among authors: karp se. J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452445 Clinical Trial.

2

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

Rosenberg SA, Lotze MT, Yang JC, Linehan WM, Seipp C, Calabro S, Karp SE, Sherry RM, Steinberg S, White DE. Rosenberg SA, et al. Among authors: karp se. J Clin Oncol. 1989 Dec;7(12):1863-74. doi: 10.1200/JCO.1989.7.12.1863. J Clin Oncol. 1989. PMID: 2685181 Clinical Trial.

3

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

Foulkes WD, Wong N, Brunet JS, Bégin LR, Zhang JC, Martinez JJ, Rozen F, Tonin PN, Narod SA, Karp SE, Pollak MN. Foulkes WD, et al. Among authors: karp se. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2465-9. Clin Cancer Res. 1997. PMID: 9815648

4

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women.

Karp SE, Tonin PN, Bégin LR, Martinez JJ, Zhang JC, Pollak MN, Foulkes WD. Karp SE, et al. Cancer. 1997 Aug 1;80(3):435-41. doi: 10.1002/(sici)1097-0142(19970801)80:3<435::aid-cncr11>3.0.co;2-y. Cancer. 1997. PMID: 9241077

5

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB. Satagopan JM, et al. Among authors: karp se. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467-73. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352856

6

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.

Restifo NP, Spiess PJ, Karp SE, Mulé JJ, Rosenberg SA. Restifo NP, et al. Among authors: karp se. J Exp Med. 1992 Jun 1;175(6):1423-31. doi: 10.1084/jem.175.6.1423. J Exp Med. 1992. PMID: 1588273 Free PMC article.

7

Retroviral transduction of interferon-gamma cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor.

Shiloni E, Karp SE, Custer MC, Shilyansky J, Restifo NP, Rosenberg SA, Mulé JJ. Shiloni E, et al. Among authors: karp se. Cancer Immunol Immunother. 1993 Oct;37(5):286-92. doi: 10.1007/BF01518450. Cancer Immunol Immunother. 1993. PMID: 8402732 Free PMC article.

8

In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor.

Karp SE, Hwu P, Farber A, Restifo NP, Kriegler M, Mulé JJ, Rosenberg SA. Karp SE, et al. J Immunol. 1992 Sep 15;149(6):2076-81. J Immunol. 1992. PMID: 1517571 Free PMC article.

9

Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor.

Karp SE, Farber A, Salo JC, Hwu P, Jaffe G, Asher AL, Shiloni E, Restifo NP, Mulé JJ, Rosenberg SA. Karp SE, et al. J Immunol. 1993 Feb 1;150(3):896-908. J Immunol. 1993. PMID: 8423345 Free PMC article.

10

Low-dose intravenous bolus interleukin-2 with interferon-alpha therapy for metastatic melanoma and renal cell carcinoma.

Karp SE. Karp SE. J Immunother. 1998 Jan;21(1):56-61. doi: 10.1097/00002371-199801000-00007. J Immunother. 1998. PMID: 9456437 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page